Danaher (DHR) Projected to Post Earnings on Wednesday

Danaher (NYSE:DHR) is expected to post its Q4 2025 results before the market opens on Wednesday, January 28th. Analysts expect Danaher to post earnings of $2.14 per share and revenue of $6.7861 billion for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, January 28, 2026 at 8:00 AM ET.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm had revenue of $6.05 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the company posted $1.71 earnings per share. The company’s quarterly revenue was up 4.4% on a year-over-year basis. On average, analysts expect Danaher to post $8 EPS for the current fiscal year and $9 EPS for the next fiscal year.

Danaher Stock Down 0.8%

DHR stock opened at $234.11 on Wednesday. The business’s 50-day moving average is $229.17 and its two-hundred day moving average is $212.44. The company has a market cap of $165.36 billion, a price-to-earnings ratio of 48.27, a P/E/G ratio of 4.20 and a beta of 0.89. Danaher has a fifty-two week low of $171.00 and a fifty-two week high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DHR. Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. Evercore ISI reaffirmed an “outperform” rating and issued a $250.00 price objective on shares of Danaher in a research note on Monday, January 5th. Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. The Goldman Sachs Group assumed coverage on shares of Danaher in a research note on Tuesday, December 9th. They set a “buy” rating and a $265.00 target price on the stock. Finally, Robert W. Baird set a $247.00 price target on shares of Danaher in a research report on Wednesday, October 22nd. Twenty-one analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $251.87.

Insider Activity at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the transaction, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 30,248 shares of company stock valued at $6,609,663. Corporate insiders own 11.20% of the company’s stock.

Institutional Investors Weigh In On Danaher

Institutional investors have recently made changes to their positions in the company. Integrated Investment Consultants LLC raised its position in Danaher by 9.5% during the 3rd quarter. Integrated Investment Consultants LLC now owns 1,722 shares of the conglomerate’s stock valued at $341,000 after purchasing an additional 149 shares in the last quarter. Aureus Asset Management LLC lifted its stake in Danaher by 37.8% in the third quarter. Aureus Asset Management LLC now owns 12,833 shares of the conglomerate’s stock worth $2,544,000 after acquiring an additional 3,520 shares during the period. Palisade Asset Management LLC grew its holdings in Danaher by 0.3% during the 3rd quarter. Palisade Asset Management LLC now owns 20,450 shares of the conglomerate’s stock worth $4,054,000 after acquiring an additional 69 shares in the last quarter. Morningstar Investment Management LLC purchased a new position in Danaher during the 3rd quarter valued at about $11,874,000. Finally, Kestra Private Wealth Services LLC lifted its position in shares of Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after purchasing an additional 48 shares during the period. Institutional investors own 79.05% of the company’s stock.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.